Literature DB >> 8841779

Assessment of bias in the SENECA study.

M A van't Hof1, J Burema.   

Abstract

OBJECTIVE: To assess manifest bias in ageing effects, i.e. longitudinal changes due to unintended time effects or to selection.
DESIGN: Mixed-longitudinal study in birth cohorts 1913-1918, with baseline measurements taken in 1988/1989 and repeated in 1993, including a short questionnaire in non-responders.
SETTING: Full baseline and follow-up data were collected in nine towns in eight European countries including Belgium, Denmark, France, Italy, The Netherlands, Portugal, Spain and Switzerland. Incomplete data were available from towns in Portugal, Poland, Northern Ireland and Connecticut, USA.
SUBJECTS: Using standardized methodologies data were collected from a random age-stratified sample of elderly men and women, including a total of 1221 re-invited subjects from nine towns and 210 newly-invited subjects from three towns in 1993.
RESULTS: An overall retrieval of 50-74% of the former participants could be reached in towns that had previously participated (apart from one exception of 41%), where estimates of mortality varied from 10% to 18%. There was a tendency for healthy and active persons to have a higher participation rate than others, as was the case for high educated newly-invited subjects compared to lower educational classes. For most of the variables used in the analysis of period effects, no evidence of any undesirable period effect was found. In those instances that period effects showed up to be statistically significant, coinciding implausible cohort effects gave the impression that these were due to instability of the estimation procedure.
CONCLUSIONS: Non-participants may be less healthy and active than the participants. Only very limited unconvincing evidence to suggest unintended time effects was observed. This confirms the high standards of the methodology and of measurements.

Entities:  

Mesh:

Year:  1996        PMID: 8841779

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

1.  ["Nutrition beyond 65"--amount of usual drinking fluid and motivation to drink are interrelated in community-living, independent elderly people].

Authors:  D Volkert; K Kreuel; P Stehle
Journal:  Z Gerontol Geriatr       Date:  2004-12       Impact factor: 1.281

2.  Ten-year trends in vitamin intake in free-living healthy elderly people: the risk of subclinical malnutrition.

Authors:  E D Toffanello; E M Inelmen; N Minicuci; F Campigotto; G Sergi; A Coin; F Miotto; G Enzi; E Manzato
Journal:  J Nutr Health Aging       Date:  2011-02       Impact factor: 4.075

3.  The impact of body mass index in old age on cause-specific mortality.

Authors:  E L de Hollander; M Van Zutphen; R P Bogers; W J E Bemelmans; L C P G M De Groot
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

4.  Ten-year trends in dietary intake, health status and mortality rates in free-living elderly people.

Authors:  E D Toffanello; E M Inelmen; N Minicuci; F Campigotto; G Sergi; A Coin; F Miotto; G Enzi; E Manzato
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

5.  Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study.

Authors:  Ala'a Alkerwi; Jessica Pastore; Nicolas Sauvageot; Gwenaëlle Le Coroller; Valéry Bocquet; Marylène d'Incau; Gloria Aguayo; Brice Appenzeller; Dritan Bejko; Torsten Bohn; Laurent Malisoux; Sophie Couffignal; Stephanie Noppe; Charles Delagardelle; Jean Beissel; Anna Chioti; Saverio Stranges; Jean-Claude Schmit
Journal:  BMC Med Res Methodol       Date:  2019-02-04       Impact factor: 4.615

6.  Cardiovascular and all-cause mortality attributable to loneliness in older Swedish men and women.

Authors:  Masuma Novak; Margda Waern; Lena Johansson; Anna Zettergren; Lina Ryden; Hanna Wetterberg; Pia Gudmundsson; Ingmar Skoog
Journal:  BMC Geriatr       Date:  2020-06-09       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.